Literature DB >> 6822878

External imaging of human atherosclerosis.

R S Lees, A M Lees, H W Strauss.   

Abstract

Autologous plasma low-density lipoproteins labeled with I-125 were used as a tracer to identify atherosclerotic lesions in the carotid arteries of the neck. Following intravenous injection of I-125-LDL, images were made at intervals from 6 to 36 hr with the gamma camera in three patients with known carotid disease and one control subject. The carotid lesions, confirmed by angiography, were imaged successfully in all three patients, whereas no focal LDL accumulation was visible in the carotid arteries of the control subject. The findings suggest that it may be possible to image atherosclerosis externally and thus to follow the course of the disease.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6822878

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  23 in total

1.  Strategic targeting of atherosclerotic lesions.

Authors:  J Narula; R Virmani; A E Iskandrian
Journal:  J Nucl Cardiol       Date:  1999 Jan-Feb       Impact factor: 5.952

2.  Imaging of unstable atherosclerotic lesions.

Authors:  Jagat Narula; H William Strauss
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-01       Impact factor: 9.236

Review 3.  Nuclear medicine and atherosclerosis.

Authors:  H Sinzinger; I Virgolini
Journal:  Eur J Nucl Med       Date:  1990

4.  Atheroma roulette.

Authors:  H William Strauss; Jagat Narula
Journal:  J Nucl Cardiol       Date:  2007 May-Jun       Impact factor: 5.952

5.  Capping it off.

Authors:  H William Strauss
Journal:  J Nucl Cardiol       Date:  2009-07-25       Impact factor: 5.952

Review 6.  Molecular imaging will replace perfusion imaging: The impossible dream.

Authors:  E Gordon Depuey
Journal:  J Nucl Cardiol       Date:  2008 May-Jun       Impact factor: 5.952

7.  Low density lipoprotein labelling characterizes experimentally induced atherosclerotic lesions in rabbits in vivo as to presence of foam cells and endothelial coverage.

Authors:  I Virgolini; P Angelberger; J O'Grady; H Sinzinger
Journal:  Eur J Nucl Med       Date:  1991

8.  Noninvasive localization of human atherosclerotic lesions with indium 111-labeled monoclonal Z2D3 antibody specific for proliferating smooth muscle cells.

Authors:  I Carrió; P L Pieri; J Narula; L Prat; P Riva; L Pedrini; E Pretolani; G Caruso; G Sarti; M Estorch; L Berná; V Riambau; X Matías-Guiu; C Pak; C Ditlow; F Chen; B A Khaw
Journal:  J Nucl Cardiol       Date:  1998 Nov-Dec       Impact factor: 5.952

9.  Z2D3 imaging: fringe or frontier?

Authors:  H W Strauss
Journal:  J Nucl Cardiol       Date:  1998 Nov-Dec       Impact factor: 5.952

10.  Polyclonal 111In-IgG, 125I-LDL and 125I-endothelin-1 accumulation in experimental arterial wall injury.

Authors:  L Prat; G Torres; I Carrió; M Roca; V Riambau; L Berná; M Estorch; I Ferrer; C García
Journal:  Eur J Nucl Med       Date:  1993-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.